Hugo Zoppé
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hugo Zoppé has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Frédérique Bonnet-Brilhault
Excellence Center in Autism and Neurodevelopmental Disorders, Regional University Hospital Centre, Tours 37000, France; University of Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, Tours 37032, France
2 shared publicationsAntoine Dupuis
Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, Poitiers 86000, France; Ecology and Biology of Interaction, CNRS UMR 7267, Poitiers Cedex 86073, France; INSERM-CIC 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, Poitiers Cedex 86021, France; BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, Poitiers Cedex 86021, France
1 shared publicationAude Rambault
Excellence Center in Autism and Neurodevelopmental Disorders, Regional University Hospital Centre, Tours 37000, France
1 shared publication- Dario Genovese
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy
1 shared publication Diane Defresne
Excellence Center in Autism and Neurodevelopmental Disorders, Regional University Hospital Centre, Tours 37000, France
1 shared publication- Emanuele Amodio
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties “G. D’Alessandro”—Hygiene Section, University of Palermo , Palermo
1 shared publication
Latest Publications
- Open Access
- 31 May 2025
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 109, 104561
Early detection of neurodevelopmental disorders in children with delayed milestones: Navigating between overlapping trajectories and the limits of a single-diagnosis categorical approach (A Preliminary Study for the CONDOR Cohort)
- 31 May 2025
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 109, 104561
Open AccessEarly detection of neurodevelopmental disorders in children with delayed milestones: Navigating between overlapping trajectories and the limits of a single-diagnosis categorical approach (A Preliminary Study for the CONDOR Cohort)
- Open Access
- 16 November 2024
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 167, 105938
Is exposure to Bisphenol A associated with Attention-deficit hyperactivity disorder (ADHD) and associated executive or behavioral problems in children? A comprehensive systematic review
- 16 November 2024
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 167, 105938
Open AccessIs exposure to Bisphenol A associated with Attention-deficit hyperactivity disorder (ADHD) and associated executive or behavioral problems in children? A comprehensive systematic review
- Open Access
- 26 January 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (3) , 729
Cranio-Facial Characteristics in Autism Spectrum Disorder: A Scoping Review
Autism spectrum disorders (ASD) consist of a complex group of neurodevelopmental disorders characterised by qualitative impairments of social interactions, communication abilities, and a limited, stereotyped, and repetitive selection of interests and activities. In light of the imperative to identify a possible biomarker for ASD, it has been determined that craniofacial anomalies serve as significant risk factors for neurodevelopmental disorders. The aim of this scoping review is to deepen the knowledge of the scientific literature related to cranio-facial characteristics in individuals with ASD, with a particular focus on recent research advancements. The review was performed by employing the search strings ((“Autism Spectrum Disorder” OR autism OR ASD OR “Autism Spectrum”) AND (“facial morphology” OR “facial phenotype”)) on the databases PubMed/MEDLINE, Scopus, and ERIC as of March 9, 2023. The review comprised seven studies whose findings were obtained through quantitative analysis of Euclidean distances between anatomical landmarks. The examination of facial abnormalities represents a possible reliable diagnostic biomarker that could aid in the timely identification of ASD. Phenotypic characteristics that may serve as predictive indicators of the severity of autistic symptoms can be observed in certain individuals with ASD by applying anthropometric and instrumental measurements. The presence of a phenotype characterised by an increased intercanthal distance and a reduced facial midline height appears to be associated with a higher degree of severity in autistic symptoms. In addition, it is worth noting that facial asymmetry and facial masculinity can be considered reliable indicators for predicting a more severe manifestation of symptoms.
- 26 January 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (3) , 729
Open AccessCranio-Facial Characteristics in Autism Spectrum Disorder: A Scoping Review
Autism spectrum disorders (ASD) consist of a complex group of neurodevelopmental disorders characterised by qualitative impairments of social interactions, communication abilities, and a limited, stereotyped, and repetitive selection of interests and activities. In light of the imperative to identify a possible biomarker for ASD, it has been determined that craniofacial anomalies serve as significant risk factors for neurodevelopmental disorders. The aim of this scoping review is to deepen the knowledge of the scientific literature related to cranio-facial characteristics in individuals with ASD, with a particular focus on recent research advancements. The review was performed by employing the search strings ((“Autism Spectrum Disorder” OR autism OR ASD OR “Autism Spectrum”) AND (“facial morphology” OR “facial phenotype”)) on the databases PubMed/MEDLINE, Scopus, and ERIC as of March 9, 2023. The review comprised seven studies whose findings were obtained through quantitative analysis of Euclidean distances between anatomical landmarks. The examination of facial abnormalities represents a possible reliable diagnostic biomarker that could aid in the timely identification of ASD. Phenotypic characteristics that may serve as predictive indicators of the severity of autistic symptoms can be observed in certain individuals with ASD by applying anthropometric and instrumental measurements. The presence of a phenotype characterised by an increased intercanthal distance and a reduced facial midline height appears to be associated with a higher degree of severity in autistic symptoms. In addition, it is worth noting that facial asymmetry and facial masculinity can be considered reliable indicators for predicting a more severe manifestation of symptoms.